Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation - A randomized controlled trial

被引:91
作者
Leviton, LC
Goldenberg, RL
Baker, CS
Schwartz, RM
Freda, MC
Fish, LJ
Cliver, SP
Rouse, DJ
Chazotte, C
Merkatz, IR
Raczynski, JM
机构
[1] Univ Alabama, Sch Publ Hlth, Dept Hlth Behav, Birmingham, AL 35294 USA
[2] Univ Alabama, Sch Med, Dept Obstet & Gynecol, Birmingham, AL USA
[3] Natl Perinatal Informat Ctr, Providence, RI USA
[4] Yeshiva Univ, Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, New York, NY 10033 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1999年 / 281卷 / 01期
关键词
D O I
10.1001/jama.281.1.46
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Antenatal corticosteroids for fetal maturation have been underused, despite evidence for their benefits in cases of preterm birth. Objective To evaluate dissemination strategies aimed at increasing appropriate use of this therapy. Design and Setting Twenty-seven tertiary care institutions were randomly assigned to either usual dissemination of practice recommendations (n = 14) or usual dissemination plus an active, focused dissemination effort (n = 13), Subjects Obstetricians and their preterm delivery cases at participating hospitals. Intervention Recommendations by a National Institutes of Health (NIH) Consensus Conference held in late February-early March 1994 were disseminated in early May 1994. Usual dissemination was publication of the recommendations and endorsement by the American College of Obstetricians and Gynecologists. Active dissemination was a year-long educational effort led by an influential physician and a nurse coordinator at each facility, consisting of grand rounds, a chart reminder system, group discussion of case scenarios, monitoring, and feedback. Main Outcome Measure Use or nonuse of antenatal corticosteroids was abstracted from medical records of eligible women delivering at the participating hospitals in the 12 months immediately prior to release of the NIH recommendations (average number of records abstracted, 130) and in the 12 months following their release (average number of records abstracted, 122). Results Active dissemination significantly increased the odds of corticosteroid use after the conference. Use increased from 33.0% of eligible patients receiving corticosteroids to 57.6%, or by 75% over baseline, in usual dissemination hospitals. Use increased from 32.9% to 68.3%, or an 108% increase, in active dissemination hospitals. Gestational age and maternal diagnosis affected use of the therapy in complex ways. Conclusion An active, focused dissemination effort increased the effectiveness of usual dissemination methods when combined with key principles to change physician practices.
引用
收藏
页码:46 / 52
页数:7
相关论文
共 27 条
[1]  
*AG HLTH CAR POL R, 1992, ANN BIBL INF DISS HL
[2]  
*AM COLL OBST GYN, 1994, COMM OP, V147
[3]   PRACTICE VARIATION IN THE USE OF CORTICOSTEROIDS - A COMPARISON OF 8 DATA SETS [J].
BRONSTEIN, JM ;
GOLDENBERG, RL .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 173 (01) :296-298
[4]  
Bronstein JM, 1998, HEALTH SERV RES, V32, P825
[5]  
BRYK AS, 1993, HIERARCHICAL LINEAR
[6]  
Burack RC, 1996, CANCER-AM CANCER SOC, V78, P1708, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1708::AID-CNCR11>3.0.CO
[7]  
2-1
[8]  
Coleman JamesS., 1966, Medical Innovation
[9]   THE EFFECTS OF CORTICOSTEROID ADMINISTRATION BEFORE PRETERM DELIVERY - AN OVERVIEW OF THE EVIDENCE FROM CONTROLLED TRIALS [J].
CROWLEY, P ;
CHALMERS, I ;
KEIRSE, MJNC .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1990, 97 (01) :11-25
[10]   EFFECT OF CORTICOSTEROIDS FOR FETAL MATURATION ON PERINATAL OUTCOMES [J].
GILSTRAP, LC ;
CHRISTENSEN, R ;
CLEWELL, WH ;
DALTON, ME ;
DAVIDSON, EC ;
ESCOBEDO, MB ;
GJERDINGEN, DK ;
GODDARDFINEGOLD, J ;
GOLDENBERG, RK ;
GRIMES, DA ;
HANSEN, TN ;
KAUFFMAN, RE ;
KEELER, EB ;
OH, W ;
SUSMAN, EJ ;
VOGEL, MG ;
AVERY, ME ;
BALLARD, PL ;
BALLARD, RA ;
CROWLEY, P ;
GARITE, T ;
GOLDENBERG, RL ;
HANKINS, GDV ;
JOBE, AH ;
KOPPE, JG ;
MAHER, JE ;
MERKATZ, IR ;
SHANKARAN, S ;
SIMPSON, KN ;
SINCLAIR, JC ;
SLOTKIN, TA ;
TAEUSCH, HW ;
WRIGHT, LL ;
ALEXANDER, D ;
BERBERICH, MA ;
BRACKEN, M ;
COOPER, L ;
CULPEPPER, L ;
ELLIOTT, JM ;
FERGUSON, JH ;
FRIGOLETTO, F ;
GAIL, DB ;
HALL, WH ;
JONES, MD ;
MEDOFFCOOPER, B ;
MERENSTEIN, GB ;
WHALEN, JM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (05) :413-418